Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

Critical Care : the Official Journal of the Critical Care Forum
Matthew E Falagas, Sofia K Kasiakou

Abstract

The increasing problem of multidrug-resistant gram-negative bacteria causing severe infections and the shortage of new antibiotics to combat them has led to the re-evaluation of polymyxins. These antibiotics were discovered from different species of Bacillus polymyxa in 1947; only two of them, polymyxin B and E (colistin), have been used in clinical practice. Their effectiveness in the treatment of infections due to susceptible gram-negative bacteria, including Pseudomonas aeruginosa and Acinetobacter baumannii, has not been generally questioned. However, their use was abandoned, except in patients with cystic fibrosis, because of concerns related to toxicity. We reviewed old and recent evidence regarding polymyxin-induced toxicity by searching Pubmed (from 1950 until May 2005). It was reported in the old literature that the use of polymyxins was associated with considerable toxicity, mainly nephrotoxicity and neurotoxicity, including neuromuscular blockade. However, recent studies showed that the incidence of nephrotoxicity is less common and severe compared to the old studies. In addition, neurotoxic effects of polymyxins are usually mild and resolve after prompt discontinuation of the antibiotics. Furthermore, cases of neuro...Continue Reading

References

Jan 1, 1977·Annual Review of Biochemistry·D R StormP E Swanson
Aug 1, 1991·Contact Dermatitis·R YokoyamaH Ueda
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·R L DannerJ E Parrillo
Oct 18, 1965·JAMA : the Journal of the American Medical Association·A F Parisi, M H Kaplan
Feb 1, 1968·Annals of Internal Medicine·L A LindesmithT L Petty
Jan 1, 1971·Annals of Internal Medicine·G Marschke, A Sarauw
Dec 1, 1974·Journal of Neurology, Neurosurgery, and Psychiatry·M VanhaeverbeekL Franken
Feb 1, 1968·Bulletin of the American College of Nurse-Midwifery·J Wiggins
Sep 1, 1970·The Journal of Pediatrics·A D Rothner, J J Parker
Sep 1, 1970·Annals of Internal Medicine·R E RandallN C Brackett
Nov 28, 1970·British Medical Journal·D J Price, D I Graham
Aug 1, 1971·Archives of Neurology·D A Decker, R W Fincham
Mar 17, 1969·JAMA : the Journal of the American Medical Association·K J RyanG E Striker
Dec 6, 1965·JAMA : the Journal of the American Medical Association·G N Gold, A P Richardson
Oct 1, 1966·Archives of Internal Medicine·C M ElwoodR C Muehrcke
Oct 1, 1966·British Journal of Urology·W BrumfittJ D Williams
Nov 1, 1966·Canadian Anaesthetists' Society Journal·H L ZauderJ Lore
Oct 1, 1966·Journal of Comparative and Physiological Psychology·W J CarrN R Wylie
May 1, 1993·Journal of Clinical Anesthesia·N E de GouwH Van Aken
Sep 1, 1995·Contact Dermatitis·A Inoue, A Shoji
Nov 1, 1996·The Journal of Membrane Biology·J R BergS A Lewis
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A S LevinS F Costa
May 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Fernandez-ViladrichA Mateu
Jun 14, 2001·Journal of Clinical Pharmacology·M D ReedJ L Blumer
Apr 17, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M E Jiménez-MejíasJ Pachón
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Garnacho-MonteroJ Madrazo-Osuna
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·John P OuderkirkJay Ward Kislak
Sep 17, 2003·Critical Care : the Official Journal of the Critical Care Forum·Nikolaos MarkouLeonidas Gregorakos
Oct 26, 1964·JAMA : the Journal of the American Medical Association·R D BAINES, D RIFKIND
Nov 2, 1964·JAMA : the Journal of the American Medical Association·R L PERKINS
Dec 1, 1964·British Journal of Pharmacology and Chemotherapy·M BARNETTS WILKINSON
Sep 1, 1959·Anesthesiology·P B SABAWALA, J B DILLON
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter K LindenDavid Paterson
Dec 12, 2003·American Journal of Physiology. Cell Physiology·Jamie R Lewis, Simon A Lewis
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A KarabinisH Malamou-Lada
Jul 23, 2004·The Journal of Antimicrobial Chemotherapy·Magdalena E SobieszczykChristine J Kubin
Sep 17, 2004·Scandinavian Journal of Infectious Diseases·Henrik NielsenDidier Raoult
Jan 12, 2005·BMC Infectious Diseases·Matthew E FalagasArgyris Michalopoulos
Feb 1, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A S MichalopoulosM E Falagas
Feb 8, 2005·Critical Care : the Official Journal of the Critical Care Forum·Argyris MichalopoulosMatthew E Falagas

❮ Previous
Next ❯

Citations

Aug 13, 2011·Molecular and Cellular Biochemistry·Mahsa AbdolhosseiniSven-Ulrik Gorr
Mar 21, 2008·The New England Journal of Medicine·L Silvia Munoz-Price, Robert A Weinstein
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Frank GuarnieriPhillip J Stone
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul ScottBruno Petruccelli
Sep 9, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jason M PogueKeith S Kaye
Aug 6, 2010·The Journal of Antimicrobial Chemotherapy·Laura S EliasAlexandre P Zavascki
Mar 24, 2012·The Journal of Antimicrobial Chemotherapy·Yun CaiNan Bai
Jun 30, 2012·The Journal of Antimicrobial Chemotherapy·Sami HraiechAntoine Roch
Oct 12, 2012·The Journal of Antimicrobial Chemotherapy·Ernest A AzzopardiDavid W Thomas
Oct 3, 2009·Current Opinion in Infectious Diseases·Roger L Nation, Jian Li
Mar 1, 2012·Antimicrobial Agents and Chemotherapy·Timothy P GauthierLaura B Smith
Apr 22, 2009·Antimicrobial Agents and Chemotherapy·Zheng MaRobert W Milne
May 1, 2013·Antimicrobial Agents and Chemotherapy·Gulsum OzkanFulya Balaban Yucesan
Jul 2, 2008·Antimicrobial Agents and Chemotherapy·Martti VaaraTimo Vaara
Jun 16, 2010·Antimicrobial Agents and Chemotherapy·Sandrine MarchandWilliam Couet
Aug 22, 2007·Antimicrobial Agents and Chemotherapy·Mart KrupovicDennis H Bamford
Aug 12, 2009·Antimicrobial Agents and Chemotherapy·Liang JinJoseph A Nicolazzo
Jul 18, 2012·Antimicrobial Agents and Chemotherapy·Cassiane Dezoti FonsecaMaria de Fátima Fernandes Vattimo
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Patrice GobinJean-Christophe Olivier
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Oct 31, 2006·Applied and Environmental Microbiology·Zengguo HeAhmed E Yousef
Dec 3, 2011·BMC Microbiology·Andrew J Manning, Meta J Kuehn
Nov 10, 2013·Annals of Clinical Microbiology and Antimicrobials·Arzu KarliSema Gulnar Sensoy
Sep 13, 2011·Annals of Intensive Care·Herbert SpapenPatrick M Honoré
Feb 9, 2012·Chest·Hannah WunschAmy L Dzierba
Jun 23, 2011·Infection and Drug Resistance·Roger SordéJordi Rello
Sep 6, 2013·Journal of the American Veterinary Medical Association·David M WongWalter H Hsu
Nov 11, 2011·International Journal of Molecular Sciences·Garry LavertyBrendan F Gilmore
Dec 19, 2013·Indian Journal of Pharmacology·Kavita SekhriHarpal Singh
Sep 11, 2009·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Suresh RamasubbanPurnendu Sekhar Das
Mar 8, 2013·Future Medicinal Chemistry·Derry K Mercer, Deborah A O'Neil
Jun 29, 2011·Future Microbiology·Matthew E FalagasPatrice Nordmann
Apr 18, 2007·Journal of Burn Care & Research : Official Publication of the American Burn Association·Jeremy GovermanRobert L Sheridan
Jan 1, 2009·The Pediatric Infectious Disease Journal·Matthew E FalagasDimitris A Kafetzis
Dec 19, 2013·The Pediatric Infectious Disease Journal·Adem KarbuzErdal İnce
Jun 6, 2013·Journal of Medicinal Chemistry·Thomas V MageeJinshan Michael Chen
Oct 12, 2010·Current Opinion in Organ Transplantation·Gopi PatelRobert A Bonomo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.